Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143)
Abstract The chemokine receptor CXCR4 mediates cell anchorage in the bone marrow (BM) microenvironment and is overexpressed in 25–30% of patients with acute myeloid leukemia (AML). Here we have shown that a new CXCR4 receptor antagonist IgG1 antibody (PF-06747143) binds strongly to AML cell lines an...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Portfolio
2017-08-01
|
| Серии: | Scientific Reports |
| Online-ссылка: | https://doi.org/10.1038/s41598-017-07848-8 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
